Israel’s EFA Technologies (see here previously) has started operations in Brazil, following approval by Anvisa (Brazil’s health regulatory authority) of EfA’s leading portable blood lab device, RevDx. Will Brazil’s President use it?
https://efa-technologies.com/efa-enters-brazilian-market-and-secures-us6-5m-in-funding-2/